Edition:
United States

Stemline Therapeutics Inc (STML.O)

STML.O on Consolidated Issue listed on NASDAQ Capital Market

12.50USD
2 Dec 2016
Change (% chg)

$-0.20 (-1.57%)
Prev Close
$12.70
Open
$12.55
Day's High
$13.00
Day's Low
$12.40
Volume
58,839
Avg. Vol
169,780
52-wk High
$14.20
52-wk Low
$3.88

STML.O

Chart for STML.O

About

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage product candidates, including SL-401, SL-701 and SL-801. SL-401 is a targeted therapy directed to the... (more)

Overall

Beta: 0.17
Market Cap(Mil.): $262.47
Shares Outstanding(Mil.): 19.16
Dividend: --
Yield (%): --

Financials

  STML.O Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -2.17 -- --
ROI: -46.89 -1.09 14.95
ROE: -47.17 -2.39 16.29

BRIEF-Stemline Therapeutics reports Q3 financial results

* Stemline Therapeutics reports third quarter 2016 financial results and highlights recent regulatory and clinical progress

Nov 08 2016

BRIEF-Stemline announces seven presentations

* Stemline announces seven presentations, including oral presentation of updated SL-401 phase 2 BPDCN data, at upcoming ASH meeting Source text for Eikon: Further company coverage:

Nov 03 2016

BRIEF-Stemline Therapeutics expect to provide further updates around multiple SL-401

* Receives Breakthrough Therapy Designation From U.S. Food And Drug Administration For SL-401

Aug 23 2016

BRIEF-Stemline Therapeutics Q2 loss per share $0.52

* Stemline Therapeutics reports second quarter 2016 financial results and highlights recent clinical progress

Aug 04 2016

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,554 -8.00
Eisai Co., Ltd (4523.T) ¥6,584 +12.00
Sumitomo Dainippon Pharma Co Ltd (4506.T) ¥1,850 +1.00
Pfizer Inc. (PFE.N) $31.63 +0.17
Novartis AG (NOVN.S) CHF68.75 -0.10
Merck & Co., Inc. (MRK.N) $61.13 +0.37
Roche Holding Ltd. (ROG.S) CHF220.60 -1.60
Roche Holding Ltd. (RO.S) CHF224.60 -1.10
Sanofi SA (SASY.PA) €75.30 +0.14
GlaxoSmithKline plc (GSK.L) 1,467.00p -1.50

Earnings vs. Estimates